Data from HIV Prevention England and the Terrence Higgins Trust show much lower levels of knowledge about HIV pre-exposure prophylaxis (PrEP) in people of Black African origin living in England than there is among gay and bisexual men, despite continuing high levels of risk behaviour and a much higher prevalence of HIV than people from… Read More »
This year’s HIV Research for Prevention (HIVR4P) virtual conference featured a large number of sessions examining PrEP usage and discontinuation rates among a variety of users, especially in Africa. Many of the presentations looked at factors that worked as incentives to keep taking PrEP. There is interest in this because, despite higher initiation rates in a… Read More »
Islatravir (MK-8591) is an antiretroviral drug with a novel mode of operation that has excited a lot of interest in the last two years because of its extraordinary persistence in the body. This means it may only need to be given once a week as an HIV treatment, and a subcutaneous implant that releases the drug might only… Read More »
While over 80% of anal sex among pre-exposure prophylaxis (PrEP) users in Amsterdam was covered by PrEP alone, condoms and PrEP were used for nearly one in five anal sex acts with casual partners. Those who opted to use condoms did so in situations of perceived vulnerability to HIV and other sexually transmitted infections (STIs)… Read More »